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Abstract
The majority ofpatients with coronary artery disease do
notfall into the well defined populations from randomized
clinical trials. Observational databases contain a rich
source of information that could be used by practicing
physicians to evaluate treatment alternatives for their
patients. We describe a computer system, the CABG
Kibitzer, which uses an integrated approach to evaluate the
treatment alternatives for CAD patients. We combine a
statistical multivariate model for calculating survival
advantages with DA techniques for assessing patient
preferences and sensitivity analysis, to create one tool that
physicians find easy to use in daily clinical practice. The
development of tools of this kind is a necessary step in
making the data ofoutcome studies accessible to practicing
physicians.
1. Introduction
The optimal treatment choice forpatients with coronary
artery disease (CAD) is highly dependent on individual patient
characteristics. Randomized clinical trials ofcarefully selected
patient groups suggest that, for younger patients with stenosis
of the left main coronary artery or three-vessel disease
combined with left-ventricular dysfunction, coronary artery
bypass graft (CABG) surgery increases life expectancy over
medical therapy. Further, in cases ofmoderate to severe angina
pectoris, surgery improves quality of life through symptom
relief [1]. Application ofthese results in the form ofguidelines
for management ofpatients with comparable characteristics is a
relatively straightforward process.
Patients notdirectly comparable with populations used
in randomized trials present difficulty. Conducting additional
trials might be considered the optimal solution; however, the
delay in obtaining results and the speed with which results
become outdated often preclude using this approach. In the
absence ofrelevant data for these patients, physicians rely on
personal experience and observational studies to guide their
clinical judgment. If not carefully controlled, however,
personal experience and observational studies can triggerfaulty
decision making through selection oravailability biases, lack of
randomization, and anchoring or adjustment difficulties [2].
Several observational databases have been developed
that provide a rich source of nonrandomized data on CAD
patients. The Duke Cardiovascular Disease Databank, in
existence since 1971, prospectively collects data on all CAD
patients seen in Duke clinics [3]. Information on medical
history, physical findings, and cardiac-catherization results are
included. A Cox proportional hazards model is used to
estimate the 1 - , 3 -, and 5 - year survival rates for medical and
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surgical patients. Several studies using this model and the
Duke database have shown that the model is able to predict
accurately the outcomes of patients from major randomized
clinical trials and toperform with more discrimination than do
human experts [3-5]. These studies indicate that with proper
statisticalprocedures, observationaldatacan be used to predict
individualpatientprognosis reliably [3-5].
Multivariate statistical models, such as the Coxmodel,
are necessary to reduce the effect ofselection bias inherent in
the nonrandomized approach. These models cancel out the
effects of known confounding prognostic factors, isolate the
effects oftherapyalternatives, and calculate survival advantages
forindividualpatients [6].
Decision-analytic (DA) techniques have also been
applied to the evaluation of patient candidacy for bypass
surgery. These techniques provide a normative method for
including individual patient preferences and lifestyles in the
therapy decision. Sensitivity analysis allows the physician to
explore how each prognostic factor influences the overall
decision. A major problem with using DA techniques in
clinical practice has been that performing probability
assessments is difficult. Forinstance, given that a patient will
have surgery at the age of 68 years and has a history of
diabetes, whatisthe chance thatthispatientwill develop angina
or die after 1, 2, or 3 years? These types of assessments are
very impractical to estimate based on subjective experience
alone.
This paper describes a computer system, the CABG
Kibitzer, which uses an integrated approach to evaluate the
treatment alternatives for CAD patients. We combine a
statisticalmultivariate model forcalculating survival advantages
with DA techniques for assessing patient preferences and
sensitivity analysis, to create one tool thatphysicians find easy
to use in daily clinical practice. The development of tools of
this kind is a necessary step in making the data of outcome
studies accessible to practicingphysicians.
2. Background
Early workdone byPliskin and associates illustrates the
difficulties ofperforming individual therapy evaluation in the
absence ofpopulation based data -- thatis, withoutknowledge
ofthe results ofrandomized clinical trials and before any large
observational databases had been tested [7]. Pliskin modeled
the decisionproblemusing adecision tree. To apply the tree to
a particular patient, physicians first were required to estimate
the probability of eight different events, many with multiple
conditional dependencies. The probability ofany event in the
model depended on patient factors such as age, gender, the
presence of other diseases (hypertension, diabetes, or
congestive heart failure), the extent ofCAD demonstrated on
angiography, and the severity ofthe patient's angina. Second, physicians estimated probabilities that were conditionallydependent on other events. In addition to the difficulties with
probability assessment, wide variations were seen among
physician estimates forthe samepatientcases. This methodfor
deriving patient-specific probabilities was clearly not feasible
forclinical use.
In the years since Pliskin's analysis, data from
randomized clinical trials and nonrandomized observational
databases have become available for simplifying the task of
probability assessment. Two CAD databases, the Duke
Databank and the Coronary Artery Surgical Study (CASS)
Registry, have been used in conjunction with multivariate
statistical models to create an improved methodology for
calculating individualprognosis.
CASS was arandomized clinical trialdesigned to study
the efficacy of surgical intervention in selected subgroups of
CAD patients [6]. Concurrent with this study, nonrandomized
patients not meeting the subgroup criteria under study were
entered into an observational database, the CASS Registry.
Carefulrecording ofsymptoms andevents overa5 - to 8 - year
periodprovided observational data onthe outcomes ofmedical
and surgical therapy for these nonrandomized patients. This
datahas been usedin several outcome studies [Gersh, 85].
Wehavedeveloped astatistical model thatreplaces the
decision-tree approach forasubsetofpatients who mustdecide
whether to undergo CABG surgery. Ourmodel calculates the
probability of individual survival given surgery or medical
therapy for geriatric patients over a user-specified number of
years. This estimate of the patient's course replaces the
decision-tree model. No estimation ofprobabilities isrequired;
only patientdataforprognostic factors -- such as age, gender,
and extent of coronary artery disease -- are needed. The
advantage of this approach is a rapid and consistent
approximate solution to the difficult problem of estimating
patient-specific probabilities. The approach is unique in the
design ofcombining statistical models with DAtechniques into
a package that any physician can feasibly use in clinical
practice.
3. Design Considerations
Two goals motivated us to develop the CABG Kibitzer.
The first was to create a computer-based tool that assists
physicians in evaluating therelative benefits ofCABG surgery
versus. other treatment alternatives (for example, medical
management orangioplasty) in CAD patients. The second was
to develop an approach for combining decision-analytic
techniques with statistical models for estimating individual
outcomes.
4. System Description
The CABG Kibitzer was developed on a MacIntosh II
computer; itrequires 2 megabytes ofRAM and Multifinder to
run. The main portion ofthe CABG Kibitzer is a HyperCard
stack; the mathematical model was written in LightSpeed
Pascal. The entire system fits on one 800 kilobyte disk. We
chose HyperCard because it allows rapid prototyping and is
easy tomaintain.
Decision analysis has been described as a cyclical
process with three stages [8]. In the initial cycle, a decision
model isformulated, evaluated, and interpreted. Iftheresultof
the firstcyclefails toconvincethedecisionmakerthataspecific
course of action is appropriate, the cycle is repeated. The
model is expanded and reevaluated, and the results are
reinterpreted. Cycling continues until the decision makerfeels
confident ofthedecision.
The CABG Kibitzer implements two cycles of the
decision-analytic process. In the firstcycle, astatistical model
calculates therelative advantage ofsurgical ormedical therapy
using patient-specific prognostic data and two simplifying
assumptions -- smoothing of operative mortality and use of
population-based values for the quality of life with angina.
These simplifications allow rapid performance of the initial
consultation. After the frt cycle has been completed, the
patient and counseling physician discuss complicating factors
and decide whether the advantages seen with the selected
therapy hold when risks not represented in the model are
considered.
A second cycle is initiated ifthe physician and patient
remain unconvinced. In this cycle, the decision model is
expanded to include additional treatment alternatives such as
angioplasty, estimation ofthe effectoflivingwith angina onthe
patient's quality oflife,risk aversion to surgicalmortality, and
pain and suffering associated with surgery. Probabilities for
outcomes are adjusted on an individual basisusingthe survival
and angina-recurrence data from the first cycle. Figure 1
illustrates the decision-analytic cycle and shows how
components ofthe CABG Kibitzer correspond to each stage.
We shalldiscuss each component in detail.
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Figure 1. Correspondence between the CABG Kibitzer and the
decision-analytic cycle. Double sidedarrows indicate components ofthe
CABG Kibitzer, single sided arrows indicate DA cycle components.
Inputto the DA cycle is a decision problem; output is a commitment to
some course ofaction.
Regardless of the structure used, the decision model
mustrepresent survivalrate and symptomcharacteristics ofthe
patient over time. In Pliskin's model, the probability of
survival, postoperative survival, and survival to years 1
through 5 with and without angina were represented by
probabilities assessed directly by physicians. The CABG
Kibitzer replaces this approach with a statistical Markov
process model.
The Markov process is a standard model for the
dynamic behavior ofprobabilistic processes [9-11]. Markov
modelspredictstateprobabilities -- thatis, thelikelihood thatan
individual orprocess willbein aparticularstate atagiventime.
Ourmodel includes three mutually exclusive states ofhealth:
alive withoutangina, alive with angina, anddeath.
The analysis estimates the probability thatapatientwill
be in each of the three states for each month over a user-
specifiednumberofmonths. Theexpected duration ofsurvival
without angina and ofsurvival with angina is calculated from
the resulting estimates. The model can predict the likelihood
that apatient will be in agiven state, as well as the duration of
the state, by treating the changes in health states as a Markov
process.
We performed a multinomial logit regression on an
observational database to determine the contribution ofknown
prognostic variables. We combined these regression
parameterswithpatient-specific variablesusing alogitfunction.
Foreachpatientconsult, estimates oftransitionprobabilities for
the Markov process model are calculated for variables such as
age, sex, and extent of disease. We combine transition
probabilities into a Markov transition matrix. One matrix is
calculated for each year in the simulation. The expected
probability of survival and of having angina for each year is
calculatedviamultiplication ofthe matrix generatedforagiven
year by the previous year. These probabilities are compared
and expected differences in survival are calculated for the two
796alternatives. Two additional calculations are then performed
using nominal and extremevaluesforlevelofpatient activity:
1. Differences inexpectedquality-adjusted life years
(QALYs) with class morIV angina
2. Jointeffect ofQALY and timediscount
Once the calculations are completed, a set ofrules is
invoked to analyze the results. The differences among the area
under the curve ofthe unadjusted survival curves, the quality-
adjusted survival curves, the time-discounted survival curves,
and the joint survival curves are used to select
recommendations for therapy and to perform more detailed
modeling.
The CABG Kibitzer provides two features that allow
the user to review the results : a plotting tool and graph-
comparison tool. Theplotting toolreads in thedatafrom a text
file created by the math model and plots the values using a
standard survival-curve format (probability ofsurvival versus
years oflife lived). The graph-comparison tool superimposes
graphs that have been created. This feature allows the user
immediately to detect stochastic dominance ofone altemative if
itexists. Figure 2 illustrates thesefeatures. The upperpanel of
this figure shows the plotted medical and surgical survival
curves fora75-year-old female with amoderatedegree ofCAD
and severe angina. The two curves are superimposed in the
lower panel; they clearly indicate the overwhelming survival
advantage forthe surgical outcome.
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Figure 3. Sensitivity analysis for the number of involved segments.
For this patient, no matter how many segments are diseased, medical
therapyisthepreferredalternative.
If reviewing the population data does not allow the
patient and physician to reach a clear decision regarding
treatment, a second cycle ofdecision analysis isperformed. In
the secondcycle, thedecision model isrefined andexpandedto
fit that particular patient's clinical scenario and personal
preferences.
The physician chooses which therapeutic alternatives to
considerin the model by menu selection (surgery, angioplasty,
or medical treatment). If angioplasty is considered as an
altemative, thephysicianestimates foreachyeartheprobability
ofsurvival and ofcontinued angina. Previousmodelestimates
of survival and occurrence of angina are displayed to help
anchor physician estimates. Modifications of the model-
generated estimates for medical and surgical alternatives can
also bemade atthistimeifnecessary.
Value-model components are selected by the physician
through consultation with the patient. The CABG Kibitzer
predefmes asetofrecommendedcomponents based onanalysis
from cycle 1. Forexample, ifan advantage for one alternative
only becomes apparent after several years, consideration of
time discount is included. Careful and frank discussion
between physician and patient is needed to identify which
components are significant. Value-model components are
chosen from a menu and include items such as "surgical pain
and suffering," and "risk aversion to operative mortality," as
well as "effect of pain" and "activity loss due to angina."
Value-model components are combined to form a patient-
specific utility function. Thetime-tradeoffapproachis used to
express the utility ofdifferentevents.
Becauseprobability andutility assessment ofoutcomes
is one ofthe mostdifficultparts ofadecision analysis, we have
explored designs to facilitate their assessment. Examples of
graphical tools to aid in assessments are shown in Figure 4.
Once outcome probabilities and time trade-offs have been
specified, themodel is assessed in theusual manner.
Figure 2. Example ofthe plotting and graph-comparison tools. The
upperpanel ofthe figure shows the graphs forthe survival rate for a 75-
year-old female with amoderate degree ofCAD and severe angina. The
bottompanel shows the graph-comparison tool which superimposes the
graphs. The top line is the rate forsurgery.
Once the graphs have beenevaluated, thephysician has
the option ofending the CABG Kibitzer session orcontinuing
with further model refinement. Sensitivity analysis can be
performed on any of the prognostic variables included in the
model. Analysis involves repeated calls to the statistical model
using incremental values ofthe chosen variable while holding
constantthe values ofall othervariables. Plotting tools similar
to the tools described previously are then used to examine the
results. An example of the results of sensitivity analysis
performed on the number of involved segments is shown in
Figure 3. For this patient, no matter how many segments are
involved in disease, the decision favors surgery over medical
therapy by acomfortablemargin.
797
U
v
v
IA
i i i i i i i i i s iiiiii'fo'i 0 -1 I
s
a
R
v
A
L I
i i i i i i i i iDractTratmeni Pain
AslassomentTool
What ste Ilngest e9 What t hobtlet what itetul pleal persd or dmr pelde eoreYe pld thatyouu dlmabll ttstya diebillrthtyou would es ct?
wmuldeopect wi wuldipecnt surgwy?
Whattectionofhit orher nonnlqualh cirlb
oouldthepetietxpectto have ntheiperlod 7
fll direcl wss wem it s [ucft eire isusessment
ImpactofPnon QualityofLife
ClassIl1 orIYangina rresuls n quntpain ofmoderate to
severoe ntensity. What decrease Inlength otIowould the
patienl acceptto live wthout thepain dueto hisorherangina ?
upaele tooalisplagr
uccEMUL *T«ue«er Yesntor *[A #TsJ i-§olHeeat
i v6.50 i Lnlg wlt
fFALM tLiving Modevt
Figure 4. Example oftools forelicitingpatientpreferences. The left
side ofthe figure is used to assess the effectofpain related to treatment
on the decision. Theright side ofthe figure is usedto assesstheaeffect
ofpain on thequality oflife.
5. System Status
The current version ofthe CABG Kibitzer includes an
entry form forpatient data, a statistical model forcalculating
patient prognosis and sensitivity analysis, and plotting and
graph-comparison tools. Several help features have been
designed to assist the user with dataentry. Figure 5 shows the
help screen developed for entering the number of involved
coronary-arterysegments. When the.userclicks dn the location
ofdiseasedsegments in thediagram, theprogramautomatically
tallies thetotal and stores the information in theproperspace on
thepatient-dataentryform.
Verification ofthe statisticalmodelandevaluation ofthe
system are underway. Verification will beperformedusing a
patientdata setthatisindependentofthe observationaldatabase
usedforinitialsystemconstruction.
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Figure 5. Help screen for the number ofinvolved segments. The user
clicks on portions ofthe diagram corresponding to stenosed segments.
Therunning total is displayed in the box on the right.
6. Discussion
In the CABG Kibitzer, wereplacesubjectiveprobability
estimates fordecision models with statistically based estimates.
A significant factor in the lack of acceptance of decision
analysis in the medicalcommunity is this method's reliance on
subjective probabilities. Obtaining subjective probability
estimates for medical decision models is difficult and time
consuming. The variability among different physicians'
estimates of outcome probabilities raises doubts for many
peopleaboutthevalidity ofdecisionanalysis. Believers counter
that although decision analysis does not guarantee a good
outcome, it does ensure a good decision based on normative
application ofthe information available. To unbelievers, the
distinction between decisions and outcomes is artificial. To be
tractable, decisionmodels containsignificantsimplifications. A
"good" decision based on seriously flawed probability
estimates in asimplifiedmodelis notreally agood decision. If
theprobabilities andsimplifications in a decision model could
bevalidatedobjectively, thenperhaps theunbelievers could be
broughttobelief.
In some sense, all probabilities are subjective. Even
withfrequency datafromcontrolledexperiments, aperson who
uses the data as the basis for a decision must believe that the
conditions under which the frequencies were observed still
hold. Nonetheless, someprobabilities aremoresubjective than
are others. We believe that a sound basis of outcome
probability infrequency dataandvalidation in theprediction of
independent observations make these probabilities less
"subjective".
Disregarding the issues ofsubjectivity, observational
data are particularly well suited for use in estimation of
outcomes for decision-analytic models. Observational
databases are available on awiderange ofpatients withvarying
severity ofdisease and otherconcomitantillnesses. RCT's are
typically performed on highly similarly patients with
uncomplicated disease. Because of the patient diversity in
observational databases, less extrapolation is needed to map from observed results to the medicalproblems of aparticular
patient. Further, observational studies are based on outcomes
oftherapeutic decisions. Because the data generated are the
products of therapeutic decisions, with proper analysis, models based on this datamay bemorepredictive ofoutcomes
of decisions than data from RCT's. In contrast, data from
RCT's aregenerated in auniquedecision-free context.
Even if the reader remains skeptical of the value of
decision-theory, implementing the results of the analysis of
outcome studies ingraphicalcomputerprograms makes sense.
Themultivariate statisticalmodelsusedtoanalyze observational
data have much more information than is easily expressed in
rules forclinical care. Scores ofrules such as "CABG extends
survival for patients who have three-vessel coronary artery
disease and reduced left-ventricular function" are needed to
express the relationships present between model parameters.
However, when the statistical models are coupled with
graphical tools such as HyperCard, vivid andpatient-specific
predictions oftheconsequences ofadecision can begenerated.
Therules can be setaside andthedatacanspeaktotheproblem
athand.
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